ERROR 1
ERROR 1
ERROR 2
ERROR 2
ERROR 2
ERROR 2
ERROR 2
Password and Confirm password must match.
If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)
ERROR 2
ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.
Chemical deal-making slowed in the first quarter of 2012, continuing a trend that began in the second half of 2011, according to a report by advisory firm PricewaterhouseCoopers. PwC recorded 16 acquisition announcements worth $50 million or more in the quarter, adding up to a total deal value of $12 billion. Last year’s first quarter posted 34 similar-size deals worth a total of $42 billion. The report blames uncertain economic indicators and weak first-quarter earnings for the drop. “Companies may have shied away from deals to streamline operations and jumpstart earnings growth through organic means,” the report suggests. Five large deals, worth $1 billion or more, drove total deal value for the quarter, but the volume of smaller deals declined substantially.
Join the conversation
Contact the reporter
Submit a Letter to the Editor for publication
Engage with us on Twitter